Related Articles
VEGI174 protein and its functional domain peptides exert antitumour effects on renal cell carcinoma
Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway
Parthenolide inhibits the tumor characteristics of renal cell carcinoma
Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression
Knockdown of LETM1 inhibits proliferation and metastasis of human renal cell carcinoma cells